Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting Antibodies
The entry of SARS-CoV-2 into host cells is mediated by the interaction between the spike receptor-binding domain (RBD) and host angiotensin-converting enzyme 2 (ACE2). Certain human antibodies, which target the spike N-terminal domain (NTD) at a distant epitope from the host cell binding surface, ha...
Egile Nagusiak: | Tina Lusiany, Tohru Terada, Jun-ichi Kishikawa, Mika Hirose, David Virya Chen, Fuminori Sugihara, Hendra Saputra Ismanto, Floris J. van Eerden, Songling Li, Takayuki Kato, Hisashi Arase, Matsuura Yoshiharu, Masato Okada, Daron M. Standley |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
MDPI AG
2023-12-01
|
Saila: | Viruses |
Gaiak: | |
Sarrera elektronikoa: | https://www.mdpi.com/1999-4915/15/12/2421 |
Antzeko izenburuak
-
Advances in antibody discovery from human BCR repertoires
nork: Zichang Xu, et al.
Argitaratua: (2022-10-01) -
Flexible, Functional, and Familiar: Characteristics of SARS-CoV-2 Spike Protein Evolution
nork: Dianita S. Saputri, et al.
Argitaratua: (2020-09-01) -
Landscape of infection enhancing antibodies in COVID-19 and healthy donors
nork: Hendra S. Ismanto, et al.
Argitaratua: (2022-01-01) -
Protein denaturation at the air-water interface and how to prevent it
nork: Edoardo D'Imprima, et al.
Argitaratua: (2019-04-01) -
Editorial: Technical Advances in Cryo-Electron Microscopy
nork: Angel Rivera-Calzada, et al.
Argitaratua: (2019-08-01)